Published on
March 4, 2024
- 13:00 GMT
Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies
Clearance to include teen patients in both the company’s open label and placebo controlled studies expected to significantly expand the number of eligible subjects, potentially expedite recruitment and lead to a more robust data set This important …
Distribution channels:
Companies, Healthcare & Pharmaceuticals Industry
...
